Avoid Fraud, Get The Facts, And Find The Best
Legal Name: BAKER BROS. ADVISORS LP
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 14, 2019
| Security |
Shares Held / Principal Amount |
Market Value |
Option |
|
SEATTLE GENETICS INC (812578102)
|
50,057,277 |
$3,464,464k |
|
|
Incyte Corp (45337C102)
|
31,976,193 |
$2,716,697k |
|
|
BEIGENE LTD-ADR (07725L102)
|
11,777,285 |
$1,459,794k |
|
|
ALEXION PHARMACEUTICALS INC CO (015351109)
|
8,258,068 |
$1,081,642k |
|
|
ACADIA PHARMACEUTCLS (004225108)
|
39,292,086 |
$1,050,277k |
|
|
B. Riley Wealth Management, Inc. (023111206)
|
41,544,288 |
$805,544k |
|
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
7,589,294 |
$650,023k |
|
|
GENOMIC HEALTH (37244C101)
|
9,260,922 |
$538,708k |
|
|
ASCENDIS PHARMA A S (04351P101)
|
3,390,270 |
$390,390k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
2,513,462 |
$258,887k |
|
|
Argenx SE Sponsored ADR (04016X101)
|
1,019,557 |
$144,349k |
|
|
Array Biopharma Inc (04269X105)
|
2,848,567 |
$131,974k |
|
|
MADRIGAL PHARMACEUTICALS INC (558868105)
|
1,169,278 |
$122,552k |
|
|
Neurocrine Biosciences Inc. (64125C109)
|
1,415,283 |
$119,492k |
|
|
HERON THERAPEUTICS INC (427746102)
|
6,018,104 |
$111,877k |
|
|
KODIAK SCIENCES INC (50015M109)
|
9,145,115 |
$106,998k |
|
|
Invitae Corp (46185L103)
|
3,902,421 |
$91,707k |
|
|
TRICIDA INC (89610F101)
|
1,969,905 |
$77,732k |
|
|
SPARK THERAPEUTICS INC (84652J103)
|
751,927 |
$76,982k |
|
|
Atreca, Inc. (04965G109)
|
3,532,760 |
$66,557k |
|
|
GW PHARMACEUTICALS PLC ADS (36197T103)
|
370,845 |
$63,930k |
|
|
INSMED INC (457669307)
|
2,462,216 |
$63,033k |
|
|
Cerus Corp (157085101)
|
10,749,937 |
$60,415k |
|
|
Rhythm Pharmaceuticals, Inc. (76243J105)
|
2,708,200 |
$59,580k |
|
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
1,787,807 |
$59,337k |
|
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
1,506,438 |
$57,034k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
1,165,411 |
$56,289k |
|
|
BIOCRYST PHARMACEUTICALS (09058v103)
|
14,382,673 |
$54,510k |
|
|
RA PHARMACEUTICALS (74933V108)
|
1,801,695 |
$54,177k |
|
|
MYOKARDIA INC (62857M105)
|
1,016,306 |
$50,958k |
|
|
DBV TECHNOLOGIES SA-SPON ADR (23306J101)
|
5,509,560 |
$45,289k |
|
|
KRYSTAL BIOTECH INC (501147102)
|
1,034,674 |
$41,666k |
|
|
CymaBay Therapeutics, Inc. (23257D103)
|
5,707,411 |
$40,865k |
|
|
NBIX 2 1/4 5/15/24 (64125CAD1)
|
30,770,000 |
$40,541k |
|
|
UNIQURE N.V. (N90064101)
|
517,700 |
$40,458k |
|
|
KINISKA PHARMACEUTIC (G5269C101)
|
2,799,577 |
$37,906k |
|
|
ZYMEWORKS INC (98985W102)
|
1,708,472 |
$37,586k |
|
|
AQUINOX PHARMACEUTICALS INC (03842B101)
|
10,934,154 |
$25,805k |
|
|
AXSOME THERAPEUTICS INC (05464T104)
|
772,286 |
$19,886k |
|
|
Xencor Inc. (98401F105)
|
428,120 |
$17,523k |
|
|
MERUS N V (N5749R100)
|
1,160,014 |
$16,994k |
|
|
BMRN 0.599 08/01/24 (09061GAH4)
|
15,000,000 |
$15,566k |
|
|
ACORDA THERAPEUTICS INC COM (00484M106)
|
2,011,189 |
$15,426k |
|
|
LA JOLLA PHARMACEUTICAL CO (503459604)
|
1,559,231 |
$14,423k |
|
|
AIMMUNE THERAPEUTICS INC (00900T107)
|
673,908 |
$14,031k |
|
|
IDERA PHARMACEUTICALS INC (45168K405)
|
4,605,822 |
$12,298k |
|
|
PROTAGONIST THERAPEUTICS INC (74366E102)
|
995,082 |
$12,050k |
|
|
MARKER THERAPEUTICS INC (57055L107)
|
1,500,000 |
$11,880k |
|
|
AEGLEA BIOTHERAPEUTICS INC (00773J103)
|
1,713,604 |
$11,738k |
|
|
Assembly Biosciences Inc (045396108)
|
803,246 |
$10,836k |
|
|
SANGAMO THERAPEUTICS (800677106)
|
999,823 |
$10,768k |
|
|
Catalyst Pharmaceuticals Inc (14888U101)
|
2,559,461 |
$9,828k |
|
|
Syros Pharmaceuticals Inc (87184Q107)
|
974,835 |
$9,027k |
|
|
ALKERMES PLC (G01767105)
|
400,000 |
$9,016k |
|
|
DERMIRA INC (24983L104)
|
906,943 |
$8,670k |
|
|
ALBIREO PHARMA INC (01345P106)
|
250,000 |
$8,060k |
|
|
APELLIS PHARMACEUTICALS INC (03753U106)
|
313,725 |
$7,950k |
|
|
MILESTONE PHARMACEUTICALS IN (59935V107)
|
266,667 |
$7,240k |
|
|
Anaptysbio Inc (032724106)
|
113,086 |
$6,380k |
|
|
ABEONA THERAPEUTICS INC (00289Y107)
|
1,288,235 |
$6,158k |
|
|
HOOKIPA PHARMA INC (43906K100)
|
892,857 |
$6,009k |
|
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
405,702 |
$5,676k |
|
|
HALOZYME THERAPEUTICS INC (40637H109)
|
299,969 |
$5,153k |
|
|
Bluebird Bio Inc (09609G100)
|
40,000 |
$5,088k |
|
|
Bellicum Pharmaceuticals Inc (079481107)
|
2,677,818 |
$4,552k |
|
|
MENLO THERAPEUTICS (586858102)
|
700,000 |
$4,193k |
|
|
G1 THERAPEUTICS INC COM (3621LQ109)
|
127,236 |
$3,901k |
|
|
NGM BIOPHARMACEUTICALS INC (62921N105)
|
250,000 |
$3,660k |
|
|
VIKING THERAPEUTICS INC COM (92686J106)
|
425,000 |
$3,528k |
|
|
Acceleron Pharma Inc (00434H108)
|
83,900 |
$3,447k |
|
|
CRINETICS PHARMACE (22663K107)
|
132,985 |
$3,325k |
|
|
GALAPAGOS NV (36315X101)
|
25,072 |
$3,233k |
|
|
ACHILLION PHARMACEUTICALS (00448Q201)
|
1,095,359 |
$2,936k |
|
|
Aravive Inc (03890D108)
|
484,947 |
$2,910k |
|
|
Xbiotech Inc (98400H102)
|
380,442 |
$2,884k |
|
|
HARPOON THERAPEUTICS INC (41358P106)
|
214,285 |
$2,786k |
|
|
FORTY SEVEN INC (34983P104)
|
250,000 |
$2,650k |
|
|
AUTOLUS THERAPEUTICS PLC (05280R100)
|
156,773 |
$2,524k |
|
|
Y-MABS THERAPEUTICS INC (984241109)
|
102,800 |
$2,351k |
|
|
CYCLERION THERAPEUTI (23255M105)
|
202,581 |
$2,320k |
|
|
SPRING BK PHARMACEUTICALS IN (849431101)
|
613,144 |
$2,263k |
|
|
NEXTCURE INC (65343E108)
|
150,000 |
$2,247k |
|
|
CYTOMX THERAPEUTICS INC (23284F105)
|
194,377 |
$2,181k |
|
|
MOLECULAR TEMPLATES INC COM (608550109)
|
254,230 |
$2,123k |
|
|
Intellia Therapeutics Inc (45826J105)
|
128,538 |
$2,104k |
|
|
IDEAYA BIOSCIENCES INC (45166A102)
|
200,000 |
$1,992k |
|
|
CHEMOCENTRYX INC (16383L106)
|
207,029 |
$1,925k |
|
|
CONSTELLATION PHARMCETICLS I (210373106)
|
133,333 |
$1,637k |
|
|
GALMED PHARMACEUTICALS LTD (M47238106)
|
215,594 |
$1,585k |
|
|
AILERON THERAPEUTICS INC (00887A105)
|
2,040,000 |
$1,469k |
|
|
DOVA PHARMACEUTICALS INC (25985T102)
|
99,405 |
$1,402k |
|
|
FOAMIX PHARMACUTICLS (M46135105)
|
498,189 |
$1,186k |
|
|
SIERRA ONCOLOGY INC (82640U107)
|
2,000,000 |
$1,120k |
|
|
ADAMAS PHARMACEUTICALS INC (00548A106)
|
172,630 |
$1,070k |
|
|
INFINITY PHARMACEUTICALS INC (45665G303)
|
580,400 |
$1,045k |
|
|
ARCUS BIOSCIENCES INC COM (03969F109)
|
121,534 |
$966k |
|
|
FULGENT GENETICS INC (359664109)
|
125,000 |
$835k |
|
|
Affimed NV (N01045108)
|
200,000 |
$574k |
|
|
AQUESTIVE THERAPEUTICS INC (03843E104)
|
99,600 |
$418k |
|
|
SUNESIS PHARMACEUTICALS INC (867328700)
|
556,665 |
$405k |
|
|
Ritter Pharmaceuticals, Inc. (767836307)
|
279,999 |
$300k |
|
|
DYNAVAX TECHNOLOGIES CORP (268158201)
|
75,000 |
$299k |
|
|
Trillium Therapeutics Inc. (89620X506)
|
505,262 |
$166k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms
Please note: Search data is accumulated by 3rd party and refreshed once per day.